IP Library Granted Patent US 9,441,254
Granted Patent B2
US 9,441,254 · App. 14/399,138 · Granted Sep 13, 2016

Process for the preparation of an intermediate for an orexin receptor antagonist

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,441,254
App. No.
14/399,138
Granted
Sep 13, 2016
Kind
B2
Abstract

The present invention is directed to processes for preparing an intermediate for a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved.

Claims (15)

1. A process for preparing a compound of the formula III:

or a salt thereof,

which comprises:

contacting a compound of the formula IV:

with a transaminase polypeptide, wherein the transaminase polypeptide is a transaminase polypeptide having the amino acid sequence of SEQ ID NO: 1 or the transaminase polypeptide of ATA-117, in the presence of a cofactor and in the presence of a weak base in a solvent, to give the compound of the formula III, or a salt thereof.

2. The process of claim 1 wherein the transaminase polypeptide is a transaminase polypeptide having the amino acid sequence of SEQ ID NO: 1.

3. The process of claim 1 wherein the transaminase polypeptide is ATA-117.

4. The process of claim 1 wherein the cofactor is a member of the vitamin B6 family.

5. The process of claim 1 wherein the cofactor is selected from the group consisting of pyridoxal (PL), pyridoxamine (PM), pyridoxine phosphate (PNP), pyridoxamine phosphate (PMP), and pyridoxal 5′-phosphate.

6. The process of claim 1 wherein the cofactor is pyridoxal 5′-phosphate.

7. The process of claim 1 wherein the weak base is selected from triethylamine, Hunig's base, triethanolamine, DBU, an inorganic carbonate, an inorganic bicarbonate, an inorganic phosphate, and an inorganic hydroxide.

8. The process of claim 7 wherein the weak base is triethylamine.

9. The process of claim 1 wherein the solvent for the process comprises a solvent that is selected from 1-methyl-2-pyrroldinone, 1-ethyl-2-pyrroldinone, DMSO, DMF, DMA, MeOH, acetonitrile and water.

10. The process of claim 9 wherein the solvent for the process comprises DMF.

11. The process of claim 1 wherein the process is conducted at a temperature between about 20 and 60° C.

Assignments (2)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2016
From: FLEITZ, FRED J.; MANGION, IAN; YIN, JINGJUN
To: MERCK SHARP & DOHME CORP.
Reel/Frame 037775/0687 →